Search results for "Nicotinic agonist"

showing 10 items of 118 documents

Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel

1991

AbstractThe reversible acetylcholine esterase inhibitor (−)-physostigmine (eserine) is the prototype of a new class of nicotinic acetylcholine receptor (nAChR) activating ligands: it induces cation fluxes into nAChR-rich membrane vesicles from Torpedo marmorala electric tissue even under conditions of antagonist blocked acetylcholine binding sites (Okonjo, Kuhlmann, Maclicke, Neuron, in press). This suggests that eserine exerts its channel-activating property via binding sites at the nAChR separate from those of the natural transmitter. We now report that eserine can activate the channel even when the receptor has been preincubated (desensitized) with elevated concentrations of acetylcholin…

Nicotinic acetylcholine receptorStereochemistryAcetylcholine-gated cation channelPhysostigmineBiophysicsCesiumIon fluxDesensitizationIn Vitro TechniquesReceptors NicotinicTorpedoBiochemistryIon ChannelsAnticholinesteraseAcetylcholine bindingGanglion type nicotinic receptorStructural BiologyMuscarinic acetylcholine receptor M5GeneticsmedicineAnimalsMolecular BiologyAcetylcholine receptorBinding SitesChemistryCell BiologyBungarotoxinsAcetylcholineNicotinic acetylcholine receptorNicotinic agonistCarbamateBiophysicsCholinergicAcetylcholineEserinemedicine.drugFEBS Letters
researchProduct

Activation of Muscarinic Receptors by Non-neuronal Acetylcholine

2011

The biological role of acetylcholine and the cholinergic system is revisited based particularly on scientific research early and late in the last century. On the one hand, acetylcholine represents the classical neurotransmitter, whereas on the other hand, acetylcholine and the pivotal components of the cholinergic system (high-affinity choline uptake, choline acetyltransferase and its end product acetylcholine, muscarinic and nicotinic receptors and esterase) are expressed by more or less all mammalian cells, i.e. by the majority of cells not innervated by neurons at all. Moreover, it has been demonstrated that acetylcholine and “cholinergic receptors” are expressed in non-neuronal organism…

Nicotinic agonistChemistryMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M5medicineMuscarinic acetylcholine receptor M4Muscarinic acetylcholine receptor M3CholinergicMuscarinic acetylcholine receptor M2Acetylcholinemedicine.drugCell biology
researchProduct

Chapter 8 Nicotinic receptors of the vertebrate CNS: introductory remarks

1996

Publisher Summary This chapter focuses on the nicotinic receptors of the vertebrate central nervous system (CNS). In vertebrates, nicotinic cholinergic neurotransmission is found in both the CNS and the periphery (muscle endplate). Although muscle and neuronal nicotinic acetylcholine receptors (nAChR) have evolved from a common ancestor, it is striking that the muscle receptor has remained rather stable in evolution, whereas the neuronal receptor has evolved to a wide diversity of subtypes. As an attractive hypothesis, neurotransmitters and neurohormones may not only interact with their archetypic cognate receptors but also with other neuroreceptor, albeit in a modulatory fashion. By modula…

Nicotinic agonistmedicine.anatomical_structureCentral nervous systemAllosteric regulationmedicinePremovement neuronal activityBiologyReceptorNeurohormonesNeuroscienceCoincidence detection in neurobiologyAcetylcholine receptor
researchProduct

Effects of (+)-tubocurarine on [3H]acetylcholine release from the rat phrenic nerve at different stimulation frequencies and train lengths

1987

The effect of (+)-tubocurarine (TC) on the release of [3H]acetylcholine from the rat phrenic nerve-hemidiaphragm preincubated with [3H]choline was investigated at different stimulation frequencies and train lengths. At 0.5 Hz (100 pulses) TC failed to modulate the evoked acetylcholine release. A slight (30%) inhibition was observed at 1 Hz (100 pulses). Release of acetylcholine evoked at 5, 25 and 50 Hz (100 pulses) or 100 Hz (200 pulses) was markedly reduced by TC. The degree of inhibition (60%) was similar between 5 Hz and 100 Hz. A concentration of 1 mumol/l TC was a maximal effective concentration at 5 Hz whilst at all higher stimulation frequencies a 10-fold higher concentration was ne…

PharmacologyChemistryTubocurarineMotor nerveRats Inbred StrainsStimulationGeneral MedicineIn Vitro TechniquesReceptors NicotinicNeurotransmissionAcetylcholineElectric StimulationRatsPhrenic NerveNicotineElectrophysiologyNicotinic agonistAnesthesiamedicineBiophysicsAnimalsAcetylcholinemedicine.drugPhrenic nerveNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Murine embryonic stem cell line CGR8 expresses all subtypes of muscarinic receptors and multiple nicotinic receptor subunits: Down-regulation of α4- …

2015

Non-neuronal acetylcholine mediates its cellular effects via stimulation of the G-protein-coupled muscarinic receptors and the ligand-gated ion channel nicotinic receptors. The murine embryonic stem cell line CGR8 synthesizes and releases non-neuronal acetylcholine. In the present study a systematic investigation of the expression of nicotinic receptor subunits and muscarinic receptors was performed, when the stem cells were grown in the presence or absence of LIF, as the latter condition induces early differentiation. CGR8 cells expressed multiple nicotinic receptor subtypes (α3, α4, α7, α9, α10, β1, β2, β3, β4, γ, δ, e) and muscarinic receptors (M1, M3, M4, M5); M2 was detected only in 2 …

PharmacologyImmunologyMuscarinic acetylcholine receptor M3Down-RegulationMuscarinic acetylcholine receptor M2Cell DifferentiationMuscarinic acetylcholine receptor M1BiologyReceptors NicotinicReceptors MuscarinicCell biologyCell LineMiceProtein SubunitsNicotinic agonistGanglion type nicotinic receptorGene Expression RegulationMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptorImmunology and AllergyAnimalsAlpha-4 beta-2 nicotinic receptorEmbryonic Stem CellsInternational immunopharmacology
researchProduct

Acetylcholine release at motor endplates and autonomic neuroeffector junctions: a comparison.

1996

Acetylcholine released at motor endplates and at autonomic neuroeffector junctions binds to nicotinic and muscarinic receptors to affect the activity of the corresponding target cells. Additionally, nicotonic and muscarinic receptors modulate various intracellular regulatory pathways (second messengers, gene expression) and mediate trophic effects. To maintain homeostasis of the individual cell and of the whole organism the release of acetylcholine has to be strictly controlled within both nervous systems. The basic events of synthesis, storage, and release are comparable at motoneurones and autonomic neurones, but mechanisms regulating transmitter release appear to differ. The motor endpla…

PharmacologyMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2BiologyMotor EndplateReceptors MuscarinicAcetylcholineNeuroeffector junctionNicotinic agonistMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptorMuscarinic acetylcholine receptor M4medicineNeuroeffector JunctionAnimalsNeuroscienceAcetylcholinemedicine.drugPharmacological research
researchProduct

The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans.

1999

1. Acetylcholine (ACh) represents one of the most exemplary neurotransmitters. In addition to its presence in neuronal tissue, there is increasing experimental evidence that ACh is widely expressed in pro- and eukaryotic non-neuronal cells. Thus, ACh has been detected in bacteria, algae, protozoa, tubellariae and primitive plants, suggesting an extremely early appearance of ACh in the evolutionary process. 2. In humans, ACh and/or the synthesizing enzyme, choline acetyltransferase, has been demonstrated in epithelial cells (airways, alimentary tract, urogenital tract, epidermis), mesothelial (pleura, pericardium) and endothelial and muscle cells. In addition, immune cells express the non-ne…

PharmacologyNeuronsPhysiologyCellular differentiationBiologyCholine acetyltransferaseAcetylcholineCell biologyEvolution MolecularParacrine signallingNicotinic agonistBiochemistryPhysiology (medical)Muscarinic acetylcholine receptormedicineCholinergicAnimalsCholinesterasesHumansAcetylcholinemedicine.drugCalcium signalingClinical and experimental pharmacologyphysiology
researchProduct

Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

2008

Animal life is controlled by neurons and in this setting cholinergic neurons play an important role. Cholinergic neurons release ACh, which via nicotinic and muscarinic receptors (n- and mAChRs) mediate chemical neurotransmission, a highly integrative process. Thus, the organism responds to external and internal stimuli to maintain and optimize survival and mood. Blockade of cholinergic neurotransmission is followed by immediate death. However, cholinergic communication has been established from the beginning of life in primitive organisms such as bacteria, algae, protozoa, sponge and primitive plants and fungi, irrespective of neurons. Tubocurarine- and atropine-sensitive effects are obser…

PharmacologyNicotinic agonistMuscarinic acetylcholine receptormedicineCholinergicBiologySignal transductionCholinergic neuronReceptorNeuroscienceAcetylcholineAcetylcholine receptormedicine.drugBritish Journal of Pharmacology
researchProduct

Biochemical Characterization of a Novel Channel-Activating Site on Nicotinic Acetylcholine Receptors

1993

We have studied the interaction of the reversible acetylcholine esterase inhibitor (-)physostigmine and several structurally related compounds with the nicotinic acetylcholine receptor (nAChR) from Torpedo marmorata electric tissue by means of ligand-induced ion flux into nAChR-rich membrane vesicles, direct binding studies and photoaffinity labeling. (-)Physostigmine acts as a channel-activating ligand at low concentrations and as a direct channel blocker at elevated concentrations. Channel activation is not inhibited by desensitizing concentrations of ACh or ACh-competitive ligands (including alpha-bungarotoxin and D-tubocurarine) but is inhibited by antibody FK1 and several other compoun…

PharmacologyPhotoaffinity labelingChemistryPhysostigmineMolecular Sequence DataIn Vitro TechniquesReceptors NicotinicTorpedoIon ChannelsAcetylcholine bindingNicotinic acetylcholine receptorNicotinic agonistnervous systemBiochemistrymedicineAnimalsChannel blockerAmino Acid SequenceBinding siteAcetylcholineAcetylcholine receptormedicine.drugJournal of Receptor Research
researchProduct

Identification of Purine Binding Sites on Torpedo Acetylcholine Receptor

1994

Electrophysiological studies from this and other laboratories have suggested a direct action of ATP on nicotinic acetylcholine receptors (nAChR). To determine the site of binding of this purine derivative, we have covalently modified the nAChR from Torpedo marmorata electrocytes employing 2-[3H]-8-azido-ATP as a photoactivable affinity label. Covalently attached radioactivity was predominantly found in the beta-polypeptide of the receptor. Based on the results of protection studies with several nAChR ligands whose target sites at the receptor are known, we conclude that the purine site(s) differ from those of acetylcholine and of physostigmine, galanthamine and related ligands, and those of…

PharmacologyPurineAzidesBinding SitesbiologyChemistryAffinity labelAffinity LabelsReceptors NicotinicTorpedolaw.inventionchemistry.chemical_compoundAdenosine TriphosphateNicotinic agonistBiochemistrylawbiology.proteinmedicineAnimalsBinding siteReceptorTorpedoAcetylcholinemedicine.drugAcetylcholine receptorJournal of Receptor Research
researchProduct